ascendis transcon glp-1 program Novo Nordisk taps in $285 million deal Glucagon-like peptide-1 receptor: mechanisms and
Description
[No authors listed] Effect of intensive therapy on residual -cell function in patients with type 1 diabetes in the diabetes control and complications trial

Their onset can be avoided or the severity reduced to a large extent if dose escalation is performed as indicated in the label, and if, while treatment lasts, a series of well-defined dietary and behavioral recommendations are followed.66 In patients who observe these recommendations, the adverse effects may disappear in a few days or weeks.67 Arguments in favor of GLP-1 receptor agonists for weight control in patients with obesity and inflammatory dermatoses As mentioned earlier, weight loss has a positive effect on the outcome and response to treatments for PsO and HS

But thats where their similarities stop

Abrupt cessation isn't medically dangerous but triggers significant appetite rebound and rapid weight regain
The altered intestinal pathway after bypass can amplify GLP-1 effects because the medication directly stimulates remaining digestive tissue at higher local concentrations
Available from: Bourgin D
